Assessment of parasite liver-stage burden in human-liver chimeric mice

Methods in Molecular Biology

Volumn 1325, Issue , 2015, Pages 59-68

  Foquet, Lander ^a   Meuleman, Philip ^a   Hermsen, Cornelus C ^a   Sauerwein, Robert ^a   Leroux Roels, Geert ^a  

^a NONE

Author keywords

Humanized mouse model; In vivo; Liver stage; Malaria; Plasmodium falciparum; qPCR; Sporozoite

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL COUNT; CHIMERA; CONTROLLED STUDY; DNA ISOLATION; ERYTHROCYTE; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LIVER; LIVER CELL; MALARIA FALCIPARUM; MOSQUITO BITE; MOUSE; NONHUMAN; PARASITE EXAMINATION; PARASITE LOAD; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMODIUM FALCIPARUM; SPECIES DIFFERENCE; ANIMAL; ANOPHELES; IMMUNOLOGY; MALARIA; MOLECULAR BIOLOGY; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; PLASMODIUM YOELII; PROCEDURES; SPOROZOITE; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANOPHELES; ERYTHROCYTES; HEPATOCYTES; HUMANS; LIVER; MALARIA; MICE; MOLECULAR BIOLOGY; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; SPOROZOITES;

EID: 84943746970     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-2815-6_5     Document Type: Chapter

References (29)

1. Leitner WW, Bergmann-Leitner ES, Angov E (2010) Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy. Malar J 9:145
2. Sauerwein RW, Roestenberg M, Moorthy VS (2011) Experimental human challenge infections can accelerate clinical malaria vaccine development. Nat Rev Immunol 11(1):57-64
3. Macchiarini F et al (2005) Humanized mice: are we there yet? J Exp Med 202(10): 1307-1311
4. Meuleman P, Leroux-Roels G (2009) HCV animal models: a journey of more than 30 years. Viruses 1(2):222-240
5. Kaushansky A et al (2014) Of men in mice: the success and promise of humanized mouse models for human malaria parasite infections. Cell Microbiol 16(5):602-611
6. Meuleman P et al (2005) Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology 41(4):847-856
7. Azuma H et al (2007) Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/-mice. Nat Biotechnol 25(8):903-910
8. Bissig KD et al (2007) Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model. Proc Natl Acad Sci U S A 104(51):20507-20511
9. Vanwolleghem T et al (2010) Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice. J Hepatol 53(3): 468-476
10. Tateno C et al (2013) Morphological and microarray analyses of human hepatocytes from xenogeneic host livers. Lab Investig 93(1):54-71
11. Braun KM, Sandgren EP (1998) Liver disease and compensatory growth: unexpected lessons from genetically altered mice. Int J Dev Biol 42(7):935-942
12. Grompe M et al (1993) Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. Genes Dev 7(12A):2298-2307
13. Wilson EM et al (2014) Extensive double humanization of both liver and hematopoiesis in FRGN mice. Stem Cell Res 13(3PA):404-412
14. Vaughan AM et al (2012) Development of humanized mouse models to study human malaria parasite infection. Future Microbiol 7(5):657-665
15. Sacci JB Jr et al (2006) Plasmodium falciparum infection and exoerythrocytic development in mice with chimeric human livers. Int J Parasitol 36(3):353-360
16. Vaughan AM et al (2012) Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. J Clin Invest 122(10):3618-3628
17. Foquet L et al (2014) Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection. J Clin Invest 124(1):140-144
18. Sack BK et al. (2013) A model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum. Infect Immun. p. IAI. 01249-13
19. Foquet L et al (2013) Molecular detection and quantification of Plasmodium falciparum-infected human hepatocytes in chimeric immune-deficient mice. Malar J 12(1):430
20. Vaughan A et al (2012) A transgenic Plasmodium falciparum NF54 strain that expresses GFPluciferase throughout the parasite life cycle. Mol Biochem Parasitol 186(2):143-147
21. Teirlinck AC et al (2013) NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections. J Infect Dis 207(4): 656-660
22. Tateno C et al (2004) Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol 165 (1fb9c63d-0fa7-8bd3-eba4-7a81d8a986dc):901-913
23. Mota MM et al (2001) Migration of Plasmodium sporozoites through cells before infection. Science 291(5501):141-144
24. Rosenberg R et al (1990) An estimation of the number of malaria sporozoites ejected by a feeding mosquito. Trans R Soc Trop Med Hyg 84(2):209-212
25. Jin Y, Kebaier C, Vanderberg J (2007) Direct microscopic quantification of dynamics of Plasmodium berghei sporozoite transmission from mosquitoes to mice. Infect Immun 75(11):5532-5539
26. Hermsen CC et al (2001) Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR. Mol Biochem Parasitol 118(2):247-251
27. Bijker EM et al (2014) Sporozoite immunization of human volunteers under mefloquine prophylaxis is safe, immunogenic and protective: a double-blind randomized controlled clinical trial. PLoS One 9(11), e112910
28. Alcoser SY et al (2011) Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts. BMC Biotechnol 11:124
29. Marcos R, Monteiro RA, Rocha E (2006) Design-based stereological estimation of hepatocyte number, by combining the smooth optical fractionator and immunocytochemistry with anti-carcinoembryonic antigen polyclonal antibodies. Liver Int 26(1):116-124